- Latest news▼
-
18:00, April 18 Daily Mail: Elderly woman in China gets infected with brain-eating amoeba
-
14:19, April 18 Obesity: exercising before breakfast helps you lose weight faster
-
10:42, April 18 The Conversation: childhood trauma can cause pathological hoarding
-
08:37, April 18 Daily Mail: Satiating food reduces cravings for sweets, nutritionist says
-
18:22, April 17 First Armenian-German Conference entitled “Heart Failure Spring School”
-
08:38, April 17 Why do kids usually recover from COVID-19 more easily than adults?
-
14:37, April 16 Daily Mail: intermittent fasting is not suitable for children and women before their periods
-
16:41, April 15 Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk
-
15:04, April 15 305 cases of measles recorded in Armenia so far in 2024
-
14:38, April 15 Food and Environmental Virology: tea contributes to effective coronavirus control
-
12:41, April 15 Daily Mail: vitamin A, B3 and E supplements can be dangerous
-
10:56, April 15 Diabetes Care: evening physical activity is good for the heart
-
08:27, April 15 Women are more susceptible to blood loss and death during bypass surgery than men, researchers say
-
18:42, April 13 WHO: Nigeria pioneers revolutionary meningitis vaccine
-
16:43, April 13 One-third of women experience menstruation-related migraines, most often during premenopause - study
All materials
Scientists offer new approach to treatment of autoimmune diseases
Specialists from the Keenan Research Center for Biomedical Science, have proposed a new approach to the treatment of autoimmune diseases, including arthritis, Medical Express reported.
According to the source, usually the treatment of such diseases is focused on suppressing the immune response, which, in fact, leads to damage to body tissues. Now, scientists propose focusing on the Ter119 inflammatory antibody, which targets red blood cells and which is an analogue of the therapy that already exists for patients with immune thrombocytopenic purpura (ITP). This is a bleeding disorder when the immune system destroys platelets. Typically, a disease is treated with a human immunoglobulin RhO antiresus (D).
Ter119 not only produced a therapeutic effect on the purpura model, but on the model of arthritis and complications caused by blood transfusion. So, Ter119 may become the basis of a new medicine, scientists are sure. Moreover, most likely, it will be able to work in the most severe cases.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- Pediatrics: Hypoglossal nerve stimulation implant helps with sleep apnea 1360
- Health minister: Simulation educational center will be created, assisted reproductive technology capacity will increase in Armenia 1316
- WHO: Nigeria pioneers revolutionary meningitis vaccine 1167
- One-third of women experience menstruation-related migraines, most often during premenopause - study 1135
- Women are more susceptible to blood loss and death during bypass surgery than men, researchers say 939
- Daily Mail: vitamin A, B3 and E supplements can be dangerous 917
- Food and Environmental Virology: tea contributes to effective coronavirus control 917
- Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk 888
- 305 cases of measles recorded in Armenia so far in 2024 881
- Diabetes Care: evening physical activity is good for the heart 871
- Daily Mail: intermittent fasting is not suitable for children and women before their periods 695
- First Armenian-German Conference entitled “Heart Failure Spring School” 489
- Why do kids usually recover from COVID-19 more easily than adults? 356
- Obesity: exercising before breakfast helps you lose weight faster 339
- The Conversation: childhood trauma can cause pathological hoarding 335
- Find us on Facebook
- Poll